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Abstract
Background: Computerized decision support systems (CDSS) are believed to have the potential
to improve the quality of health care delivery, although results from high quality studies have been
mixed. We conducted a systematic review to evaluate whether certain features of prescribing
decision support systems (RxCDSS) predict successful implementation, change in provider
behaviour, and change in patient outcomes.
Methods: A literature search of Medline, EMBASE, CINAHL and INSPEC databases (earliest entry
to June 2008) was conducted to identify randomized controlled trials involving RxCDSS. Each
citation was independently assessed by two reviewers for outcomes and 28 predefined system
features. Statistical analysis of associations between system features and success of outcomes was
planned.
Results: Of 4534 citations returned by the search, 41 met the inclusion criteria. Of these, 37
reported successful system implementations, 25 reported success at changing health care provider
behaviour, and 5 noted improvements in patient outcomes. A mean of 17 features per study were
mentioned. The statistical analysis could not be completed due primarily to the small number of
studies and lack of diversity of outcomes. Descriptive analysis did not confirm any feature to be
more prevalent in successful trials relative to unsuccessful ones for implementation, provider
behaviour or patient outcomes.
Conclusion: While RxCDSSs have the potential to change health care provider behaviour, very
few high quality studies show improvement in patient outcomes. Furthermore, the features of the
RxCDSS associated with success (or failure) are poorly described, thus making it difficult for system
design and implementation to improve.
Published: 11 February 2009
BMC Medical Informatics and Decision Making 2009, 9:11 doi:10.1186/1472-6947-9-11
Received: 10 April 2008
Accepted: 11 February 2009
This article is available from: http://www.biomedcentral.com/1472-6947/9/11
© 2009 Mollon et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Informatics and Decision Making 2009, 9:11 http://www.biomedcentral.com/1472-6947/9/11
Page 2 of 9
(page number not for citation purposes)
Background
Prescribing skills are core to the practice of medicine. As
in most developed countries, prescription drugs are cur-
rently the fastest growing cost category in Canadian
healthcare, exceeding $22 billion annually and increasing
at 10.5% yearly [1]. With this increase in medication pre-
scribing follows the potential for adverse drug events,
including prescribing errors. It is estimated that medica-
tion errors occur in 57 per 1000 orders, with 18.7 – 57.7%
of these errors having the potential for harm [2]. The sug-
gestion that detection of preventable errors by health care
professionals could improve patient safety and reduce the
cost of adverse drug events [3], has been sufficient to
spawn a multitude of medication safety initiatives with
limited rigorous evaluation of their benefits and harms.
Although they have several uses, the main interest in elec-
tronic health records (EHR) and computerized decision
support systems (CDSS) is to improve patient outcomes
by influencing the decision making process of providers
[4-6]. CDSS provide patient-specific advice by using algo-
rithms to compare patient characteristics against a knowl-
edge base [7-9]. Prescribing CDSS (RxCDSS) specifically
deal with medications and can support basic (e.g. check-
ing for drug-drug interactions) to complex (e.g. integrat-
ing patient-specific diagnoses, risk factors, and prior
treatments to make a drug recommendation) functions
[10]. These systems may include, but do not require, a for-
mal e-prescribing link with pharmacies.
Reviews evaluating the literature surrounding decision
support have noted that technologies have the potential
to improve practitioner performance, but effects on
patient outcomes are still unclear [11-15]. Several features
have been linked with successful clinical decision support.
These include use of a computer to generate the decision
support based on automated EHR data analysis, including
provision of recommendations instead of just assess-
ments, and provision of the decision support at the time
and location of decision-making and in synchrony with
usual clinician workflow [11,12,14,15].
However, only one of these reviews [14] limited their
analysis to high quality evidence (randomized controlled
trials). None of the reviews systematically separated out-
comes by their natural hierarchy of difficulty – system
implementation, provider behaviour change and patient
outcomes, and focused on features predicting success ver-
sus failure for each outcome domain. Finally, while one
review was limited to drug order entry systems [14], no
study to date has examined all RxCDSS irrespective of the
presence of this system feature.
Our objective was to conduct a systematic review of rand-
omized trials, to evaluate the effectiveness of RxCDSS
using a hierarchical approach to defining success, and to
determine which features of system design or implemen-
tation were associated with the success or failure of
RxCDSS implementation, change in provider behaviour,
and change in patient outcomes.
Methods
The two primary research questions of this review were:
(1) When evaluated rigorously in randomized controlled
trials, have current RxCDSS successfully been imple-
mented and altered physician prescribing or patient out-
comes? Furthermore, (2) what features of these RxCDSS
are associated with success versus failure? Based on the lit-
erature and our own experience, we hypothesized that: a)
high quality studies of RxCDSS may report successful
implementation, but fewer have changed prescriber
behaviour and fewer still have demonstrated improved
patient outcomes and b) a number of RxCDSS features
will be associated with successful versus unsuccessful out-
comes as defined above.
RxCDSS Features
Potentially important features were identified primarily
from our own e-health research program and clinical
experience [16] as well as reviews of the literature
[11,12,17-19]. A list of 40 features was generated, 12 fea-
tures were ultimately removed during the review process
due to lack of reporting or inability to assess. The remain-
ing 28 features were grouped into 4 categories: Pure tech-
nical features, Technical/user interactions, Logic of
decision support, and Developmental and Administrative
environment (see Figure 1; Additional File 2).
Study Inclusion/Exclusion
We included reports of RCTs of RxCDSS published in Eng-
lish. We considered a RxCDSS to be an intervention which
utilized a computer to analyze patient-specific informa-
tion to advise a prescriber (primarily a physician) or phar-
macist when they were writing or filling a prescription,
respectively. Although the decision support itself had to
be generated electronically, the support could be deliv-
ered by any means (e.g. computer terminal, fax, mail,
patient record insert). We only considered systems which
intervened before a drug therapy had been chosen by a
physician, or had the ability to suggest alternate therapies
(i.e. a drug different then that initially prescribed) to be a
RxCDSS. These are the more challenging decisions for
which to intervene and change. Systems whose sole pur-
pose was to offer 'fine-tuning' advice on a pre-defined
therapy – usually dose modification – were not included
in this review. Systems primarily focused on diagnosis,
vaccination, or nutrition, were also excluded.
Search Strategy
We searched the databases Medline, EMBASE, CINAHL,
and INSPEC for articles published since the earliest entryBMC Medical Informatics and Decision Making 2009, 9:11 http://www.biomedcentral.com/1472-6947/9/11
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to June 2008. The detailed search strategy is shown in
Additional File 3. The search was individually tailored for
each database, with search terms from domains of study
methodology, general CDSS terms and RxCDSS identifi-
ers. These included: randomized controlled trial, artificial
intelligence, decision support systems, computer-assisted
therapy, computerized medical records system, reminder
systems, hospital information systems, computer systems,
decision support techniques, ambulatory care informa-
tion systems, computer assisted decision making, medical
errors, therapeutic uses, drug therapy, drug information
services, drug interactions, drug monitoring, guideline
adherence, medication systems, drug administration
schedule, drug costs, drug dose-response relationship,
and computer assisted drug therapy. A pilot test was com-
pleted to ensure that known relevant studies were identi-
fied. All citations obtained were downloaded into
Reference Manager, version 11.0.
Study Selection
The titles of all returned studies were reviewed, and those
potentially matching our definition of a RxCDSS were
kept. Next, the abstracts were assessed independently by
two reviewers to determine whether the studies met the
inclusion criteria. Disagreements between reviewers were
resolved by consensus and, if necessary, by arbitration of
a third reviewer. If uncertain whether a study met the
inclusion criteria, it moved to the next stage of assessment
in order to decrease the likelihood that a relevant study
was overlooked.
During full-text review, articles were once again reviewed
independently using detailed data extraction forms which
extracted details on methods, study validity, study out-
comes and features. Before use, the data extraction forms
were critiqued for face validity by a panel of methodolo-
gists experienced in systematic reviews and CDSS. The
forms were also piloted to improve usability.
Analysis
Methodological quality of each RCT was assessed using a
modified scale adapted from Garg et al [11]. Our rating
system assessed studies on four potential sources of bias:
unit of allocation, presence of baseline differences
between groups potentially linked to study outcomes,
objectiveness of outcome, and completeness of follow-up.
Each source of bias was rated on a scale of 0 to 2, with 2
indicating the highest methodological quality. The results
of this evaluation were summed with a maximum total
possible score of 8.
Study outcomes were assessed for success in each of our
three domains of focus: 'Implementation', 'Change in
Health Care Provider Behaviour', and 'Change in Patient
Outcomes'. Implementation was considered successful if
the RxCDSS was successfully introduced and utilized by
the clinical staff. A successful change in provider behav-
iours required reporting of changes such as a decrease in
inappropriate prescribing or a change to a more cost-effec-
tive therapy. Lastly, impact on patient outcomes was con-
sidered successful if the study reported improvements in
List of RxCDSS features evaluated Figure 1
List of RxCDSS features evaluated. This figure summarizes the RxCDSS features evaluated in this review.
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patients' health (e.g. decreases in morbidity or mortality).
These domains of outcomes were hypothesized to be con-
ditional and hierarchical, with success required in imple-
mentation before changes in provider behaviour would
be noted, and so on. Since the concept of minimal clini-
cally important difference in this area of research remains
undefined, outcomes were assessed for statistical signifi-
cance as reported by the original study [20].
Each RCT report was reviewed several times independ-
ently to ensure complete abstraction of features of inter-
est. Each feature on our list was rated for each study as
present, absent, or could not assess. 'Could not assess' was
used when, even after extensive discussion, reviewers
could not agree that a feature was present or absent. For
the purposes of analysis, features that could not be
assessed were considered absent.
Consensus was obtained as described above for methodo-
logical quality scores, RxCDSS success and presence/
absence of features. Descriptive statistics were used to
characterize the studies included, their degree of success,
and the number of features reported. Inter-rater reliability
for selected methodological quality score, success and fea-
tures present or not, was calculated and reported as a
kappa statistic. We planned to measure the association
between our three-tier definition of success of the individ-
ual studies and the feature list using univariate binary
logistic regression. This method requires roughly equiva-
lent numbers of successful and unsuccessful studies per
outcome. Statistical analyses were conducted using SAS
9.1 (Cary, North Carolina).
Results
Our search protocol returned 4534 unique citations
(1179 from Medline, 1072 from EMBASE, 1053 from
CINAHL, and 1204 from INSPEC plus an additional 26
from the reference lists). Of these, 332 abstracts were eval-
uated, and 110 were chosen for full text review (see study
flow diagram in Figure 2). At this stage, 33 (30%) were
removed for not meeting initial inclusion criteria (18 did
not deal with prescribing, 7 were not randomized control-
led trials, 3 were not drug-related, 3 were extension studies
or interim analysis, 1 was a foreign language study, and 1
did not use a computer to offer the decision support). In
addition, 36 (32.7%) were deemed to be a drug dosing
CDSS and were excluded. The final review sample con-
sisted of 41 studies (see Additional File 4) [9,21-60].
Study flow diagram Figure 2
Study flow diagram. This diagram details the flow of citations through each stage of this systematic review.
4534 citations identified 
332 Abstracts evaluated
110 studies warrant full-text evaluation
41 Studies Included in Final Sample
4202:  Citation judged irrelevant   removed
222:     Abstract judged irrelevant  removed
36:  Dosing CDSS only
18:  Other form of CDSS 
7: Not  RCTs
3: Not  drug-related
3:  Extension studies or   
interim analysis
1:  System was not 
electronic
1: Foreign  language
removedBMC Medical Informatics and Decision Making 2009, 9:11 http://www.biomedcentral.com/1472-6947/9/11
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Key ratings, such as study quality and successful imple-
mentation showed good agreement, with kappa estimates
of 0.62 (95% CI 0.50–0.73; weighted) and 0.77 (0.48 –
1.00) respectively. However, the features in the individual
studies were more difficult to rate (see Additional File 5).
Although the proportion of agreement for the presence of
a feature was substantial, varying from 58.1% to 93%, the
nature of the kappa statistic resulted in scores such as for
'CDSS supports the user's task at hand' at 0.14 (95% CI -
0.18 to 0.46). Ultimately, the consensus rating for each
variable was used for final data analysis.
Description of Studies
The 41 RCTs involved a total of 612,556 patients (range
169–407,460 per study) and 2963 providers (range 17–
334 per study). The mean methodological score was 5.9
with a range of 2–8, indicating generally good quality
studies. Twenty-three studies (56.1%) used a RxCDSS in
an outpatient general practice or internal medicine set-
ting, 10 (24.4%) in inpatient hospital wards or emergency
rooms, 5 (12.2%) in pharmacies and 3 (7.3%) in specialty
clinics (2 for paediatrics and 1 for diabetes). The systems
addressed a variety of problems – cardiovascular care
(36.6%), general/internal medicine (29.3%), diabetes
(9.8%), respiratory disease (9.8%), otitis media (7.3%),
depression, osteoporosis and infectious disease (2.4%
each). Nineteen (46.3%) of the RxCDSS were integrated
with drug order entry, 16 (39.0%) with management/elec-
tronic health record (EHR) software and 9 (22.0%) also
printed the suggestions. While 20 (48.8%) of these sys-
tems appeared to be developed by independent vendors,
21 (51.2%) were developed within an (experienced)
home EHR environment such as the Regenstreif Medical
System [61] and the Veterans Health Information System
[62].
The studies most often employed a traditional 2-arm par-
allel design (31, or 75.6%), although 6 studies (14.6%)
used a 3-arm design and 4 (9.8%) used a 2 × 2 factorial
design. The nature of the control arm of studies was also
mixed but most often was labelled as usual care (35 or
85.4%). The remaining 6 studies employed a control
group intervention that was felt to be much less effective
such as distribution of general treatment guidelines or
education, reminders regarding an unrelated condition or
a RxCDSS that operated with reduced functionality.
Systems were successfully implemented in 37 trials
(90.2%) [21-23,25-30,32,33,35-60], provider behaviour
changed in 25 (61%) [21-23,25,26,28,29,32,33,35,37,41,
43-45,47,48,50,51,53,55-57,59,60], and patient out-
comes improved in 5 (12.2%) [28,44-46,59]. Only 23
RCTs reported on this important outcome and all of the
studies reporting success with a patient outcome were
published after 2005. Of those studies reporting improve-
ments in patient outcomes, Kucher et al. [44] noted a
computer program encouraging prophylaxis against deep-
vein thrombosis and pulmonary embolism reduced the
risk of these two events by 41% at 90 days (P = 0.001).
Javitt et al. [28] found a system that scanned administra-
tive claims and clinical data to detect physician errors
reduced hospital admissions by 19% in the intervention
group relative to the control group (P < 0.001). Feldstein
et al. [59] used patient-specific guideline reminders within
the primary care physician's EHR to improve osteoporosis
management for HMO patients who had suffered a previ-
ous fracture. Lester et al. [45] used e-mail reminders to
physicians to encourage the increased use of lipid-lower-
ing medication for patients with coronary artery disease.
Roumie et al. [46] examined strategies to improve blood
pressure control and found that patient education com-
bined with computerized patient-specific alerts to provid-
ers was superior to provider education alone.
Association Between CDSS Features and Outcomes
These associations are shown in detail in Additional File
1. Overall, studies mentioned an average of 17 features
each (see Additional File 6). No trial concentrated on the
features and their relationship with success or failure of
the intervention nor did any trial systematically identify
all of the features of their intervention. Only one study
[21] isolated a specific RxCDSS feature through their ran-
domization procedure. In this study, no benefit was
found by adding bibliographic citations to electronic
reminders. Another study [42] randomized two groups to
guideline-based suggestions for treating congestive heart
failure versus these suggestions plus others based on
symptoms gleaned from the linked EHR, and found that
the intervention group fared worse in terms of more hos-
pitalizations. As this study did not have a control arm
without a RxCDSS, it was not considered further in the
analysis of features.
Because of the small number of studies, the lack of rigor-
ous attention to features descriptions by the trials and,
especially, the lack of diversity of outcomes across the 3
domains, we were unable to statistically evaluate whether
there are features more associated with success than fail-
ure using logistic regression as originally planned. In gen-
eral, the features most prevalent across the 40 remaining
studies included: support of the user's task at hand (95%),
provision of decision support at the time and place of
decision-making (85%), provision of a recommendation
rather than just an assessment (85%), automatic provi-
sion of decision support as part of clinician workflow
(78%), integration with charting or order entry (75%),
and convenient locations for the computers (68%). How-
ever, with few exceptions, the prevalence of these features
was similar between successful and unsuccessful studies
when examining implementation, provider behaviourBMC Medical Informatics and Decision Making 2009, 9:11 http://www.biomedcentral.com/1472-6947/9/11
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and patient outcomes. For patient outcomes, there was
reasonable separation for the prevalence of a few features.
The features which all of the successful studies [28,44-
46,59] shared and which most of the unsuccessful studies
did not, included: provision of a recommendation rather
than just an assessment, justification of decision support
via provision of research evidence and the system uses
data standards that support integration. However these
results should be considered hypothesis-generating at
best, given the low number of studies which successfully
altered patient outcomes and the poor general reporting
of features.
Discussion
We have systematically reviewed the literature surround-
ing RxCDSS. The distribution of success in these 41 stud-
ies – the majority successfully implemented, more than
half reporting changes in provider process but only five
were able to successfully impact patient-related outcomes,
appears to validate our hierarchal definition of success.
The primary finding of the review is the continued poor
reporting of and, by implication, the poor attention to sys-
tem design and implementation features [12]. The lack of
rigorous attention to and reporting of intervention fea-
tures severely hampers progress in this field. All CDSS are
by definition, complex interventions meaning mutifacto-
rial, multidisciplinary and usually multi-staged [20,63].
If the ideal set of features was known, these could be high-
lighted and those more likely to be wasteful of time and
resources could be dropped. For example, an activity with
enormous cost in time and effort such as training and sup-
port of users, would rapidly change if high quality evi-
dence suggested that only selected components and
timing were the key to success.
The small number of trials and the lack of consistent
reporting of features in the individual studies prevented
statistical analysis of associations of features with out-
comes. The descriptive examination of feature prevalence
and their association with success versus failure returned
no clear message.
The strengths of this review include a detailed search pro-
tocol tailored to four individual databases, the explicit use
of a comprehensive features list, and a multi-level evalua-
tion of system success. However, our study was limited, as
mentioned, by the small sample size of included studies
and the lack of systematic reporting of system features.
Publication bias is always a possibility and is difficult to
refute – in this case there may be an under-representation
of negative studies. Many studies were excluded because
the interventions dealt only with drug dosing suggestions.
This group of studies should be systematically reviewed
separately; it may well be that the simplicity of dosing
decision support is an easier area to build success than
complex processes of connecting diagnosis with therapy
in light of contraindications, allergies and co-medica-
tions.
Despite the substantial interest and investment in devel-
oping electronic decision aids [64-68], our review sup-
ports the results of others who have noted a lack of
demonstrated impact on clinically important patient out-
comes [11-13]. Only 23 studies reported on patient out-
comes; of these, 5 were successful. In the limited literature
that evaluated such endpoints, patient outcomes were fre-
quently secondary outcomes, with resultant lack of power
to detect a difference between the intervention and con-
trol groups. This speaks to the lack of mature research pro-
grams in this field as well as the difficulties organizing and
completing these difficult, complex intervention trials.
Conclusion
This systematic review suggests that electronic prescribing
decision support systems can be implemented and have
the potential to change clinician behaviours, but there is
no consistent translation into improved patient out-
comes. We have demonstrated that trials do not ade-
quately report and may not give sufficient attention to
features of their system design and implementation. We
believe that the lack of attention to evidence-based opti-
mization of RxCDSS interventions continues to hamper
the development and implantation of these essential sys-
tems.
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